EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multiplex Polymerase Chain Reaction Panels for Gastrointestinal Infections: Current Evidence, Regulatory Hurdles, and the Way Forward

Giannoula S Tansarli iD, David R Allen iD, Ferric C Fang iD

Open Forum Infectious Diseases · 22.10.2025 · 12 (Supplement_2) · S1418-S1430

DOI: 10.1093/ofid/ofaf445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 22.10.2025. Verfasst von Giannoula S Tansarli und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, Washington, USA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, bioMérieux.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Syndromic multiplex polymerase chain reaction (PCR) panels have revolutionized the diagnosis of gastrointestinal infections, allowing the rapid and simultaneous detection of multiple pathogens, including rare or difficult-to-identify organisms, with superior analytic sensitivity as compared with conventional methods. Although multiplex PCR panels are costly, their costs are offset by lower health care costs resulting from improved diagnostic accuracy and more targeted therapy. However, significant barriers to reimbursement may discourage providers from ordering PCR panels or incentivize them to use smaller panels that are less comprehensive. Addressing these challenges will require a collaborative effort, including regulators, payors, and clinicians. Key steps will include updating clinical guidelines to better define appropriate utilization of gastrointestinal panels, harmonizing reimbursement criteria to align with evidence-based practice, and modernizing diagnostic codes for acute gastroenteritis to match payors’ requirements. These reforms will be essential to improve access to advanced diagnostics and ensure better patient care.

Schlagwörter

Stichwörter der Autor:innen

diarrheagastroenteritismolecular diagnosticsreimbursementsyndromic testing

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, Washington, USA.
  • US Medical Affairs, bioMérieux, Salt Lake City, Utah, USA.
  • Department of Microbiology, School of Medicine, University of Washington, Seattle, Washington, USA.

ORCID-Profile: Giannoula S Tansarli, David R Allen, Ferric C Fang

Förderung

  • NIAID NIH HHS
  • bioMérieux

Zitieren

APA

Tansarli, G. S., Allen, D. R., & Fang, F. C. (2025). Multiplex Polymerase Chain Reaction Panels for Gastrointestinal Infections: Current Evidence, Regulatory Hurdles, and the Way Forward. Open Forum Infectious Diseases, 12(Supplement_2), S1418-S1430. https://doi.org/10.1093/ofid/ofaf445

Vancouver

Tansarli GS, Allen DR, Fang FC. Multiplex Polymerase Chain Reaction Panels for Gastrointestinal Infections: Current Evidence, Regulatory Hurdles, and the Way Forward. Open Forum Infectious Diseases. 2025;12(Supplement_2):S1418-S1430. doi:10.1093/ofid/ofaf445

BibTeX
@article{Tansarli2025,
  author = {Tansarli, Giannoula S and Allen, David R and Fang, Ferric C},
  title = {Multiplex Polymerase Chain Reaction Panels for Gastrointestinal Infections: Current Evidence, Regulatory Hurdles, and the Way Forward},
  journal = {Open Forum Infectious Diseases},
  year = {2025},
  volume = {12},
  number = {Supplement_2},
  pages = {S1418--S1430},
  doi = {10.1093/ofid/ofaf445}
}
Kostenlos starten →